Maureen E. Lane

Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases

Nancy Chan, Amy D. Willis, Naomi Kornhauser et al. · Clinical Cancer Research · 2016 · 225 citations

Medicine, Cancer Biology, Oncology +17

Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies.

Della Makower, Alla M. Rozenblit, Howard Kaufman et al. · PubMed · 2003 · 150 citations

Medicine, Oncology, Surgery +17

3D culture broadly regulates tumor cell hypoxia response and angiogenesis via pro-inflammatory pathways

Peter DelNero, Maureen E. Lane, Scott S. Verbridge et al. · Biomaterials · 2015 · 142 citations

Medicine, Cancer Biology, Cell Biology +14

Phase II Proof-of-Concept Study of Pazopanib Monotherapy in Treatment-Naive Patients With Stage I/II Resectable Non–Small-Cell Lung Cancer

Nasser K. Altorki, Maureen E. Lane, Thomas Bauer et al. · Journal of Clinical Oncology · 2010 · 139 citations · Full text

Medicine, Oncology, Pharmacology +14

Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse

Sarika Jain, Jules Cohen, Maureen M. Ward et al. · Annals of Oncology · 2013 · 96 citations · Full text

Medicine, Cancer Biology, Oncology +13